Fludarabine
Colon Cancer
Essen BiotechSmall moleculePhase 1/2Active
CCC
52/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 47/ 100
- Competitive Position
- 65/ 100
Competitive context
157 Active assets in the Colon Cancer cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
FLUOROURACILUM Akeso | Phase 4 | A |
Irinotecan Fudan University | Phase 3 | BBB |
Floxuridine City of Hope Medical Center | Phase 2 | BBB |
FLUOROURACILUM Akeso | Phase 4 | BB |
Eloxatin Sun Yat-sen University | Phase 3 | BB |
View all 50 →
Same molecule, other indications
Fludarabine is also rated in:
acute myeloid leukemia with abnormal bone marrow eosinophils inv(16)(p13q22) or t(16;16)(p13;q22)Dormant
BBB
Indicative ·
76 / 100
View asset →Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →